uniquemedicallabs.com

FOLLISTATIN 344 – 1ML

$119.00

Facebook
Email
WhatsApp

Follistatin 344 is a research peptide variant of the follistatin protein containing 344 amino acids, known to bind myostatin and activin-A, modulating TGF-β signaling. Preclinical studies show it promotes muscle differentiation and regulates growth factor balance via Smad2/3 inhibition. Follistatin 344 is utilized in biochemical and regenerative research investigating peptide–cytokine signaling.

For research use only. Not for human consumption.

Additional information

Research Applications

  • Mechanistic studies of activin neutralization and activin receptor signaling modulation

  • Experimental interrogation of myostatin/activin pathway crosstalk within TGF-β superfamily networks

  • Cell-based assays evaluating SMAD pathway activation, transcriptional responses, and ligand competition dynamics

  • Preclinical model investigations of pathway-regulated tissue remodeling, fibrosis markers, and inflammatory signaling endpoints

  • Comparative analyses across follistatin isoforms and engineered variants in controlled laboratory settings

⚠️ Important Warnings and Disclaimers

Product Guidelines

  • Product intended for experimental and research purposes only.

  • Do not use without proper technical knowledge.

  • Keep refrigerated as per storage guidelines.

  • Results may vary based on genetics, diet, and lifestyle.

  • Keep out of reach of children.

  • Store according to technical instructions.

  • Do not reuse vials or materials.

  • Do not purchase if you have any doubts regarding its use.

Limitation of Liability The company is not responsible for:

  • Misuse or incorrect administration.

  • Adverse reactions or interactions with other medications.

  • Consequences resulting from self-medication.

  • The buyer assumes full responsibility for all risks associated with handling and utilization.

📌 Legal Compliance This product is marketed as a research chemical, in compliance with international laboratory supply practices. The sale of this product does not constitute an offer for medical treatment.